|
AU2002300983B2
|
|
Azolo Triazines And Pyrimidines
|
|
AU1201101A
|
|
Bicyclic and tricyclic amines as modulators of chemokine receptor activity
|
|
AU7997600A
|
|
Amino lactam sulfonamides as inhibitors of abeta protein production
|
|
AU5588400A
|
|
1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
|
|
AU4203500A
|
|
Pyrazolopyrimidines as crf antagonists
|
|
AU4327600A
|
|
Aryl sulfonyls as factor xa inhibitors
|
|
AU4181000A
|
|
Novel lactam inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase
|
|
AU4180900A
|
|
Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase
|
|
AU2381600A
|
|
Thrombin or factor xa inhibitors
|
|
AU2057200A
|
|
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
AU3126700A
|
|
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
AU6508899A
|
|
Selective eradication of virally-infected cells by combined use of a cytotoxic agent and an antiviral agent
|
|
AU5777299A
|
|
Isoxazolo(4,5-d)pyrimidines as CRF antagonists
|
|
AU4584199A
|
|
Cyclic carbamates and isoxazolidines as iib/iiia antagonists
|
|
AU4698299A
|
|
5-HT7 receptor antagonists
|
|
AU4698399A
|
|
1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
|
|
AU4692399A
|
|
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
AU4821899A
|
|
A process for the preparation of macrocyclic metalloprotease inhibitors
|
|
AU4074799A
|
|
Substituted aryl hydroxamic acids as metalloproteinase inhibitors
|
|
AU3213799A
|
|
Integrin antagonists
|
